Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $836.7M
Liabilities Breakdown FY2025
Total Liabilities: $188.8M
Asset Breakdown
Total Assets: $836.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $120.5M | 14.4% |
| Accounts Receivable | $59.8M | 7.1% |
| Inventory | $12.9M | 1.5% |
| Property, Plant & Equipment | $1.9M | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $641.6M | 76.7% |
Liabilities Breakdown
Total Liabilities: $188.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $40.4M | 21.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $148.4M | 78.6% |